Debevoise partners Andrew L. Bab and Paul D. Rubin will conduct a Practising Law Institute webinar on recent trends in healthcare mergers and acquisitions. This comprehensive briefing will cover the potential effects of regulatory reform, private equity investments in healthcare and how trends are reshaping the rapidly changing industry.

Mr. Bab is a corporate partner, member of the firm’s Mergers & Acquisitions and Private Equity Groups, and co-head of the Healthcare Group. Mr. Bab has worked extensively on public and private acquisitions, divestitures and joint ventures, including cross-border transactions for both private equity and corporate clients, as well as licensing arrangements and other corporate transactions. Mr. Rubin is a corporate partner based in the Washington, D.C. office and a member of the Healthcare Group. His practice focuses on FDA/FTC regulatory matters.

The Debevoise Healthcare Group employs a highly coordinated, multidisciplinary approach to address transactional, litigation and intellectual property matters for leading healthcare companies and for private equity firms investing in the industry. The team provides integrated, cross practice legal advice with efficient and seamless execution covering all aspects of healthcare matters, including corporate and M&A, litigation and compliance, FDA/FTC regulatory, intellectual property, including licensing and collaboration agreements, and cyber security & data privacy.

Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.